C33H41ClN6O2
Neat
589.19
Room Temperature
THIQ; 312637-48-2; (3R)-N-[(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1, 2, 4-triazol-1-ylmethyl)piperidin-1-yl]-1-oxopropan-2-yl]-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxamide; (3R)-N-[(1R)-1-[(4-Chlorophenyl)methyl]-2-[4-cyclohexyl-4-(1H-1, 2, 4-triazol-1-ylmethyl)-1-piperidinyl]-2-oxoethyl]-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide; (3R)-N-((1R)-1-((4-Chlorophenyl)methyl)-2-(4-cyclohexyl-4-(1H-1, 2, 4-triazol-1-ylmethyl)-1-piperidinyl)-2-oxoethyl)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide; (3R)-N-((2R)-3-(4-chlorophenyl)-1-(4-cyclohexyl-4-(1, 2, 4-triazol-1-ylmethyl)piperidin-1-yl)-1-oxopropan-2-yl)-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxamide; RefChem:1050256; (R)-N-((R)-1-(4-((1H-1, 2, 4-triazol-1-yl)methyl)-4-cyclohexylpiperidin-1-yl)-3-(4-chlorophenyl)-1-oxopropan-2-yl)-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxamide; CHEMBL339053; N-[(1R)-1-[(4-Chlorophenyl)methyl]-2-[4-cyclohexyl-4-(1H-1, 2, 4-trazol-1-ylmethyl)-1-piperidinyl]-2-oxoethyl]-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxamide; (3R)-N-[(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1, 2, 4-triazol-1-ylmethyl)piperidin-1-yl]-1-oxidanylidene-propan-2-yl]-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxamide; (3R)-N-[(1R)-1-[(4-Chlorophenyl)methyl]-2-[4-cyclohexyl-4-(1H-1, 2 and 4-triazol-1-ylmethyl)-1-piperidiny; C33H41ClN6O2; GTPL1338; orb1298894; SCHEMBL1920108; SCHEMBL29365479; DTXSID00953320; HLCHESOMJVGDSJ-LOYHVIPDSA-N; GLXC-05256
(3R)-N-[(2R)-3-(4-chlorophenyl)-1-[4-cyclohexyl-4-(1, 2, 4-triazol-1-ylmethyl)piperidin-1-yl]-1-oxopropan-2-yl]-1, 2, 3 and 4-tetrahydroisoquinoline-3-carboxamide
InChI=1S/C33H41ClN6O2/c34-28-12-10-24(11-13-28)18-30(38-31(41)29-19-25-6-4-5-7-26(25)20-36-29)32(42)39-16-14-33(15-17-39,21-40-23-35-22-37-40)27-8-2-1-3-9-27/h4-7,10-13,22-23,27,29-30,36H,1-3,8-9,14-21H2,(H,38,41)/t29-,30-/m1/s1